Jan 26, 2024
1:12
For every 12 shares held, investors received 1. The price per share adjusted from $0.57 to $6.89.
The split itself did not change the total investment value.
Inovio Pharmaceuticals, Inc. (LSE:0A43) operates in the Pharmaceuticals: major industry.
Inovio Pharmaceuticals, Inc. company overviewInovio Pharmaceuticals, Inc.'s most recent stock split was on January 26, 2024. It was a 1-for-12 reverse split, so shareholders received 1 share for every 12 they held.
Inovio Pharmaceuticals, Inc. (LSE:0A43) has split its stock 3 times: a 1-for-4 reverse split on September 13, 2004, a 1-for-4 reverse split on June 6, 2014, and a 1-for-12 reverse split on January 26, 2024.
Inovio Pharmaceuticals, Inc. has split its stock 3 times. This history records 3 reverse splits between September 13, 2004 and January 26, 2024.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Inovio Pharmaceuticals, Inc.'s 1-for-12 reverse split on January 26, 2024, every 12 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Inovio Pharmaceuticals, Inc. has not announced a new split in our records. Its most recent split was on January 26, 2024, 2 years ago. Companies announce splits in advance, and any new LSE:0A43 split will appear on this page.